论文部分内容阅读
在1971年—1980年的10年中,日本文献报道的嗜铬细胞瘤手术是129例,其中术中发现的有8例,作者就此进行了综述,并从麻醉角度做了分析。随着术前、术中,术后管理的进步,术前已确诊的嗜铬细胞瘤死亡率已明显减少,Apgar 报道1951年以前是24%,1957年到1971年佐藤报道是6%,作者统计的1971年至1980年死亡率已下降到3.5%。术前未诊断嗜铬细胞瘤,而术中突然出现高血压及心律不齐者,其死亡率很高,Apgar 报道是50%、佐藤报道是43%,而作者统计的8例中除1例情况不明外,其它术后全部存活。麻醉医生遇到的嗜铬细胞瘤主要有以下三种情况:(1)术前诊断明确;
In the 10 years from 1971 to 1980, 129 cases of pheochromocytoma surgery were reported in the Japanese literature. Among them, 8 cases were found during the operation. The author reviewed the results and analyzed it from the perspective of anesthesia. With advances in preoperative, intraoperative, and postoperative management, the preoperative pheochromocytoma mortality has been significantly reduced. Apgar reported 24% before 1951 and Sato reported 6% between 1957 and 1971. The mortality rate from 1971 to 1980 has fallen to 3.5%. Preoperative pheochromocytoma was not diagnosed, but sudden high blood pressure and arrhythmia occurred during surgery. The mortality rate was high, 50% reported by Apgar and 43% by Sato. The authors’ statistics included 8 cases except 1 case. Unknown conditions, all other postoperative survival. Pheochromocytoma encountered by anesthesiologists mainly has the following three conditions: (1) Preoperative diagnosis is clear;